- A new vaccine may stop melioidosis.
- Melioidosis is a disease from soil bacteria.
- The bacteria live in soil and groundwater.
- They can cause a serious lung infection.
- The bacteria can enter wounds or be inhaled.
- Researchers tested the vaccine on monkeys in lab studies.
- The vaccinated animals had no lung damage.
- Scientists want to try the vaccine in people.
- The disease happens mostly in warm coastal places.
Difficult words
- vaccine — a medicine that helps prevent an infection
- melioidosis — a disease caused by soil bacteria
- bacterium — a very small living thing that can cause diseasebacteria
- groundwater — water that is under the ground
- inhale — to breathe air into the lungsinhaled
- coastal — near the sea or ocean
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Have you had a vaccine?
- Do you live near the sea?
- Would you try a new vaccine for a serious disease?
Related articles
Nepal’s cement industry: growth, jobs and pollution
After the 2015 Gorkha earthquake, Nepal expanded cement production with large investments, especially from Chinese firms. By 2019 it became self-sufficient and started exports to India in July 2022, while social and environmental problems grew.
Vigorous exercise helps sleep in older adults with mild cognitive impairment
A small Texas A&M study used Oura Rings to track seven older adults with mild cognitive impairment for 14 days. Vigorous exercise gave the largest sleep benefit; light activity helped a little and moderate exercise showed no clear effect.
Antibody and EGFR–STAT1 pathway point to new fibrosis treatments
Researchers at Yale found a human antibody that blocks epiregulin and lowers fibrosis markers. They also show EGFR activates STAT1 in fibroblasts, suggesting two treatment paths: block epiregulin or target the EGFR–STAT1 pathway.
